Latest Developments in Global Point Of Care Molecular Diagnostics Market

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Point Of Care Molecular Diagnostics Market

  • Healthcare
  • Upcoming Report
  • Oct 2024
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

  • In February 2022, Sense Biodetection entered into a strategic agreement with Una Health (Una) for the United Kingdom distribution of the Veros Covid-19 test
  • In December 2021, FIND invested USD 21 million in Biomeme, Bioneer, Qlife, and SD Biosensor to accelerate the development, manufacturing, and launch of affordable point-of-care molecular diagnostic platforms that can detect multiple pathogens that cause diseases including COVID-19

Frequently Asked Questions

The market is segmented based on Global Point of Care Molecular Diagnostics Market Segmentation, By Product and Services (Assays and Kits, Instruments/Analyzers, Software and Services),  Technology (Polymerase Chain Reaction-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based, Isothermal Nucleic Acid Amplification Technology (INAAT), Others), Test Location (Over The Counter, Point of Care), Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-Acquired Infections, Oncology, Hepatitis, Hematology, Prenatal Testing, Endocrinology, Others), End User (Physician Offices, Hospital Emergency Departments and Intensive Care Units, Research Institutes, Home-Care, Decentralized Labs, Assisted Living Healthcare Facilities, Others) – Industry Trends and Forecast to 2031. .
The Global Point Of Care Molecular Diagnostics Market size was valued at USD 3.86 USD Billion in 2023.
The Global Point Of Care Molecular Diagnostics Market is projected to grow at a CAGR of 13.4% during the forecast period of 2024 to 2031.
The major players operating in the market include Abbott, Siemens Healthineers AG, Quidel Corporation, F. Hoffman-La Roche , Danaher, BD, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech plc, Instrumentation Laboratory, Nova Biomedical, PTS Diagnostics, Sekisui Diagnostics, Thermo Fisher Scientific, bioMérieux S.A., DiaSorin S.p.A, AccuBioTech Co. , Meridian Bioscience, Biocartis Bioscience, GeneSTAT Molecular Diagnostics LLC, Terumo Corporation, Grifols S.A .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..